 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
2gyy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.2.1.11
- Aspartate-semialdehyde dehydrogenase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Lysine biosynthesis (early stages)
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-aspartate 4-semialdehyde + phosphate + NADP+ = L-4-aspartyl phosphate + NADPH
|
 |
 |
 |
 |
 |
L-aspartate 4-semialdehyde
|
+
|
phosphate
|
+
|
NADP(+)
|
=
|
L-4-aspartyl phosphate
|
+
|
NADPH
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
oxidation-reduction process
|
7 terms
|
 |
|
Biochemical function
|
binding
|
9 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
281:31031-31040
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Examination of key intermediates in the catalytic cycle of aspartate-beta-semialdehyde dehydrogenase from a gram-positive infectious bacteria.
|
|
C.R.Faehnle,
J.Le Coq,
X.Liu,
R.E.Viola.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Aspartate-beta-semialdehyde dehydrogenase (ASADH) catalyzes a critical branch
point transformation in amino acid bio-synthesis. The products of the aspartate
pathway are essential in microorganisms, and this entire pathway is absent in
mammals, making this enzyme an attractive target for antibiotic development. The
first structure of an ASADH from a Gram-positive bacterium, Streptococcus
pneumoniae, has now been determined. The overall structure of the apoenzyme has
a similar fold to those of the Gram-negative and archaeal ASADHs but contains
some interesting structural variations that can be exploited for inhibitor
design. Binding of the coenzyme NADP, as well as a truncated nucleotide
analogue, into an alternative conformation from that observed in Gram-negative
ASADHs causes an enzyme domain closure that precedes catalysis. The covalent
acyl-enzyme intermediate was trapped by soaking the substrate into crystals of
the coenzyme complex, and the structure of this elusive intermediate provides
detailed insights into the catalytic mechanism.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIGURE 2. NADP-induced domain closure in spASADH. Binding
of NADP induces an 8° rotation of the N-terminal Rossmann
fold toward the C-terminal dimerization domain. A, ribbon
representation of spASADH domain closure induced by the binding
of NADP. Shown is the opened form of spASADH with the moving
domain (red), hinge-bending residues (green), and fixed domain
(blue) highlighted. The hinge-bending axis is shown as black
spheres. B, overlay of the opened form of spASADH (colored as in
A) with the closed form (yellow). NADP is shown as modeled in
the spASADH-NADP complex (white sticks). C, plot of C- backbone
displacement in the opened to closed transition versus amino
acid residue (moving residues, red; hinge residues, green; fixed
residues, blue).
|
 |
Figure 3.
FIGURE 3. Interactions between ASADH and NADP. A, NADP
(yellow sticks) forms several interactions with spASADH in the
closed form (green sticks), including electrostatic and hydrogen
bonding interactions (...) and cation- interactions with the
adenine ring (   ). An overlay of the
opened form structure (white sticks) allows visualization of the
side chain movements that take place to accommodate NADP
binding. B, in contrast, the adenine ring of NADP occupies a
completely different binding pocket in ecASADH (11), whereas the
positions of the 2'-phosphate group and the nicotinamide ring
are maintained.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2006,
281,
31031-31040)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.S.Evitt,
and
R.J.Cox
(2011).
Synthesis and evaluation of conformationally restricted inhibitors of aspartate semialdehyde dehydrogenase.
|
| |
Mol Biosyst, 7,
1564-1575.
|
 |
|
|
|
|
 |
B.T.Arachea,
X.Liu,
A.G.Pavlovsky,
and
R.E.Viola
(2010).
Expansion of the aspartate beta-semialdehyde dehydrogenase family: the first structure of a fungal ortholog.
|
| |
Acta Crystallogr D Biol Crystallogr, 66,
205-212.
|
 |
|
|
|
|
 |
D.V.Camper,
and
R.E.Viola
(2009).
Fully automated protein purification.
|
| |
Anal Biochem, 393,
176-181.
|
 |
|
|
|
|
 |
R.E.Viola,
X.Liu,
J.F.Ohren,
and
C.R.Faehnle
(2008).
The structure of a redundant enzyme: a second isoform of aspartate beta-semialdehyde dehydrogenase in Vibrio cholerae.
|
| |
Acta Crystallogr D Biol Crystallogr, 64,
321-330.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Vyas,
V.Kumar,
S.Panjikar,
S.Karthikeyan,
K.V.Kishan,
R.Tewari,
and
M.S.Weiss
(2008).
Purification, crystallization and preliminary X-ray diffraction analysis of aspartate semialdehyde dehydrogenase (Rv3708c) from Mycobacterium tuberculosis.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 64,
167-170.
|
 |
|
|
|
|
 |
C.A.Hutton,
M.A.Perugini,
and
J.A.Gerrard
(2007).
Inhibition of lysine biosynthesis: an evolving antibiotic strategy.
|
| |
Mol Biosyst, 3,
458-465.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|